Amgen Buy or Sell Recommendation

Macroaxis provides Amgen Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Amgen positions. The advice algorithm takes into account all of Amgen Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Amgen buy-and-hold prospective. Check also Amgen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon

  

Risk Tolerance

  
Symbol
Execute Advice
Amgen Inc -- USA Stock  

USD 186.64  0.88  0.47%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Amgen Inc is 'Strong Buy'.
For the selected time horizon Amgen Inc has a risk adjusted performance of 0.15, jensen alpha of 0.2503, total risk alpha of 0.1177, sortino ratio of 0.4903 and treynor ratio of 0.245
Macroaxis provides buy, hold, or sell suggestion on Amgen Inc to complement and cross-verify current analyst consensus on Amgen Inc. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Amgen is not overpriced, please confirm all Amgen Inc fundamentals including its EBITDA, Cash Flow from Operations and the relationship between Price to Book and Total Debt . Given that Amgen Inc has Price to Earning of 16.98 times, we suggest you validate Amgen Inc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.44Value At Risk-1.0399
Potential Upside2.4184Standard Deviation1.1562
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Fmr LlcCommon Shares57 M9.8 B
Capital Research Global InvestorsCommon Shares53.7 M9.3 B
Vanguard Group IncCommon Shares52.1 M9 B
Blackrock IncCommon Shares49.5 M8.5 B
State Street CorpCommon Shares33 M5.7 B
Primecap Management CoCommon Shares23 M4 B
Northern Trust CorpCommon Shares9.3 M1.6 B

Amgen Greeks

α
Alpha over DOW
= 0.25 
βBeta against DOW= 1.74 
σ
Overall volatility
= 1.21 
 IrInformation ratio = 0.28 

Amgen Volatility Alert

Amgen Inc exhibits relatively low volatility with skewness of 0.88 and kurtosis of 0.37. However, we advice investors to further investigate Amgen Inc to make sure all market statistics is disseminated and is consistent with investors' estimations about Amgen upside potential.
    
 Better Than Average     
    
 Worse Than Average Compare Amgen to competition
FundamentalsAmgenPeer Average
Return On Equity26.43 % (15.17) %
Return On Asset8.27 % (15.64) %
Profit Margin35.46 % (5.50) %
Operating Margin44.49 % (10.91) %
Current Valuation64.22 B152.14 B
Shares Outstanding729.68 M1.43 B
Shares Owned by Insiders0.14 % 6.91 %
Shares Owned by Institutions80.47 % 18.37 %
Number of Shares Shorted7.81 M3.24 M
Price to Earning16.98 times40.69 times
Price to Book4.30 times14.44 times
Price to Sales5.90 times17.81 times
Revenue23.05 B9.85 B
Gross Profit18.83 B21.75 B
EBITDA12.36 B1.41 B
Net Income8.17 B517.71 M
Cash and Equivalents39.23 B3.89 B
Cash per Share53.76 times5.17 times
Total Debt35.06 B7.36 B
Debt to Equity110.50 times0.72 times
Current Ratio6.20 times3.30 times
Book Value Per Share43.41 times13.64 times
Cash Flow from Operations10.47 B1.25 B
Short Ratio2.81 times2.09 times
Earnings Per Share10.98 times2.30 times
Price to Earnings To Growth3.63 times1.22 times
Number of Employees17.9 K10.67 K
Beta1.790.34
Market Capitalization136.06 B29.78 B
Total Asset71.58 B126.86 B
Retained Earnings(438 M)38.24 B
Working Capital29.85 B3.58 B
Current Asset38.52 B36.8 B
SellBuy
Strong Buy

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Amgen exotic insider transaction detected [view details]
Risk Adjusted Performance0.15
Market Risk Adjusted Performance0.255
Mean Deviation0.9094
Downside Deviation0.6641
Coefficient Of Variation264.55
Standard Deviation1.16
Variance1.34
Information Ratio0.2816
Jensen Alpha0.2503
Total Risk Alpha0.1177
Sortino Ratio0.4903
Treynor Ratio0.245
Maximum Drawdown4.28
Value At Risk(1.04)
Potential Upside2.42
Downside Variance0.4411
Semi Variance(0.11)
Expected Short fall(1.33)
Skewness0.8772
Kurtosis0.3657

Current Valuation

Amgen Current Valuation Analysis
Amgen Inc is rated third in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Pharmaceuticals And Biosciences industry is presently estimated at about 376.26 Billion. Amgen retains roughly 64.22 Billion in current valuation claiming about 17% of equities listed under Pharmaceuticals And Biosciences industry.